Trial Profile
Liposomal doxorubicin and estramustine phosphate: a phase II study in taxane resistant, hormone refractory advanced prostate cancer
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Estramustine (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 14 Nov 2006 Status change
- 03 Nov 2005 New trial record.